Gerrit Jan Weverling

7.1k citations
88 papers · 5.0k indexed · 1 hit paper · h-index 40
  • Virology top 0.2%
    • HIV Research and Treatment 32
    • HIV/AIDS drug development and treatment 29
    • HIV/AIDS Research and Interventions 20
  • Hepatology top 2%
    • Influenza Virus Research Studies 8
    • Respiratory viral infections research 7
    • Cytomegalovirus and herpesvirus research 7
    • Virus-based gene therapy research 7
    • Viral-associated cancers and disorders 7

Gerrit Jan Weverling

88 papers receiving 4.8k citations

Hit Papers

Plasma tau, neurofilament light chain and amyloid-β level...215202020262022202450100150200

Peers

Gerrit Jan Weverling
Comparison fields: 5 of 133
  • Virology 1.6k
  • Infectious Diseases 2.5k
  • Hepatology 426
  • Emergency Medicine 495
  • Epidemiology 1.6k
Replace Paul R. Skolnik with:
Paul R. Skolnik United States
Jonathan B. Angel Canada
Mauro Moroni Italy
Massimo Andreoni Italy
Marshall J. Glesby United States
Antonella Castagna Italy
Michael H. Grieco United States
Peter Skinhøj Denmark
Harold A. Kessler United States
Guido Antonelli Italy
Gerrit Jan Weverling relative to Paul R. Skolnik United States Paul R. Skolnik's profile →
Citations per field
00.5×2.9×
Paul R. Skolnik · 1×
Citations per year

Countries citing papers authored by Gerrit Jan Weverling

Since Specialization
Citations

This map shows the geographic impact of Gerrit Jan Weverling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Jan Weverling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Jan Weverling more than expected).

Fields of papers citing papers by Gerrit Jan Weverling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Jan Weverling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Jan Weverling. The network helps show where Gerrit Jan Weverling may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerrit Jan Weverling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit Jan Weverling Line = papers co-authored together Gerrit Jan Weverling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200939
2 200844
3 200536
4 200562
5 2004205
6 200447
7 200333
8 200314
9 20026
10 200224
11 200226
12 200123
13 20015
14 20013
15 200075
16 200051
17 200082
18 1999148
19 199787
20 19953

About Gerrit Jan Weverling

Gerrit Jan Weverling is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 88 papers that have together received 5.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (29 papers), HIV/AIDS Research and Interventions (20 papers), Influenza Virus Research Studies (8 papers), Virus-based gene therapy research (7 papers), Viral-associated cancers and disorders (7 papers), Respiratory viral infections research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (2.5k citations) and Hepatology (426 citations). Gerrit Jan Weverling has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Joep M. A. Lange, Jaap Goudsmit, Suzanne Jurriaans, Peter Reiss, Ferdinand W N M Wit, Hanneke Schuitemaker, Roel A. Coutinho, Jan W. Mulder, Richard M. W. Hoetelmans and Ferdinand W.N.M. Wit. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026